SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-24-048774
Filing Date
2024-04-18
Accepted
2024-04-18 14:33:50
Documents
2
Group Members
NOVARTIS BIDCO AGNOVARTIS PHARMA AG

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2410988d11_sc13d.htm SC 13D 127464
2 EXHIBIT 1 tm2410988d11_ex1.htm EX-1 8203
  Complete submission text file 0001104659-24-048774.txt   137378
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Subject) CIK: 0001340243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90872 | Film No.: 24853956
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)